Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Front Oncol. 2021 Feb 5:10:637880. doi: 10.3389/fonc.2020.637880. eCollection 2020.

¹ Interventional and Medical Oncology Unit, IRCCS Istituto Tumori "G. Paolo II", Bari, Italy.
² Pharmacy Unit, IRCCS Istituto Tumori "G. Paolo II", Bari, Italy.
³ Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
⁴ Department of Health Science, Digestive Surgery Unit, University "Magna Graecia" Medical School, Germaneto, Italy.
⁵ Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine "G. Baccelli", University of Bari Medical School, Bari, Italy.
⁶ Nuclear Medicine Unit, D.I.M., University of Bari "Aldo Moro", Bari, Italy.

Abstract

[This corrects the article .].

Keywords: bevacizumab; chemotherapy; hyperthermia; metastatic colon cancer; tumor angiogenesis.